These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 6769305)

  • 21. Additive anticonvulsant effect of flunarizine and sodium valproate on electroshock and chemoshock induced seizures in mice.
    Joseph S; David J; Joseph T
    Indian J Physiol Pharmacol; 1998 Jul; 42(3):383-8. PubMed ID: 9741653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Facilitation action of N-acetylcysteine on the anticonvulsant effect of sodium valproate in mice.
    Devi PU; Pillai KK; Vohora D
    Basic Clin Pharmacol Toxicol; 2006 May; 98(5):521-2. PubMed ID: 16635113
    [No Abstract]   [Full Text] [Related]  

  • 23. Anticonvulsant and acute neurotoxic effects of imperatorin, osthole and valproate in the maximal electroshock seizure and chimney tests in mice: a comparative study.
    Luszczki JJ; Wojda E; Andres-Mach M; Cisowski W; Glensk M; Glowniak K; Czuczwar SJ
    Epilepsy Res; 2009 Aug; 85(2-3):293-9. PubMed ID: 19406619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-glutamatergic effect of riluzole: comparison with valproic acid.
    Kim JE; Kim DS; Kwak SE; Choi HC; Song HK; Choi SY; Kwon OS; Kim YI; Kang TC
    Neuroscience; 2007 Jun; 147(1):136-45. PubMed ID: 17507170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitory mediation of catecholamines for anticonvulsant activity of sodium valproate.
    Parmar SS; Chaturvedi AK; Geiger JD; Brumleve SJ
    Proc West Pharmacol Soc; 1982; 25():327-30. PubMed ID: 6812065
    [No Abstract]   [Full Text] [Related]  

  • 26. The anticonvulsant profile of rufinamide (CGP 33101) in rodent seizure models.
    White HS; Franklin MR; Kupferberg HJ; Schmutz M; Stables JP; Wolf HH
    Epilepsia; 2008 Jul; 49(7):1213-20. PubMed ID: 18325020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholecalciferol enhances the anticonvulsant effect of conventional antiepileptic drugs in the mouse model of maximal electroshock.
    Borowicz KK; Morawska M; Furmanek-Karwowska K; Luszczki JJ; Czuczwar SJ
    Eur J Pharmacol; 2007 Nov; 573(1-3):111-5. PubMed ID: 17643415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anticonvulsant profile of nimodipine and nitrendipine against pentylenetetrazole induced seizures in rats.
    Balakrishnan S; Bhargava VK; Pandhi P
    Indian J Exp Biol; 1999 Apr; 37(4):340-3. PubMed ID: 10641168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of sodium valproate and flunarizine administered alone and in combination on pentylenetetrazole model of absence seizures in rat.
    Shantilal P; David J; Joseph T
    Indian J Exp Biol; 1999 Mar; 37(3):228-33. PubMed ID: 10641150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticonvulsant drug effects in the direct cortical ramp-stimulation model in rats: comparison with conventional seizure models.
    Krupp E; Löscher W
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1137-49. PubMed ID: 9618416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the anticonvulsant, behavioral and pharmacokinetic interaction profiles of stiripentol in combination with clonazepam, ethosuximide, phenobarbital, and valproate using isobolographic analysis.
    Luszczki JJ; Ratnaraj N; Patsalos PN; Czuczwar SJ
    Epilepsia; 2006 Nov; 47(11):1841-54. PubMed ID: 17116023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thalidomide inhibits pentylenetetrazole-induced seizures.
    Palencia G; Calderon A; Sotelo J
    J Neurol Sci; 2007 Jul; 258(1-2):128-31. PubMed ID: 17449064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Furosemide potentiates the anticonvulsant action of valproate in the mouse maximal electroshock seizure model.
    Luszczki JJ; Sawicka KM; Kozinska J; Borowicz KK; Czuczwar SJ
    Epilepsy Res; 2007 Aug; 76(1):66-72. PubMed ID: 17659862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phenobarbitone and sodium valproate interaction: an experimental study.
    Mesdjian E; Valli M; Bruguerolle B; Jadot G; Bouyard P; Mandel P
    Prog Neuropsychopharmacol; 1980; 4(3):247-52. PubMed ID: 6776548
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of valproic acid on levels of GABA and glutamic acid in pentylenetetrazole-damaged rat brain.
    Calderón Guzmán D; Espitia Vázquez I; Barragán Mejía G; Labra Ruiz N; Rodríguez Pérez R; Santamaria del Angel D; Ayala Guerrero F; Juárez Olguín H
    Proc West Pharmacol Soc; 2003; 46():48-50. PubMed ID: 14699883
    [No Abstract]   [Full Text] [Related]  

  • 36. Enhanced anticonvulsant activity of ganaxolone after neurosteroid withdrawal in a rat model of catamenial epilepsy.
    Reddy DS; Rogawski MA
    J Pharmacol Exp Ther; 2000 Sep; 294(3):909-15. PubMed ID: 10945840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of sodium valproate and ethosuximide on phenobarbital plasma protein binding.
    Patsalos PN; Lascelles PT
    Neurology; 1982 Sep; 32(9):1052-3. PubMed ID: 6810205
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of sodium valproate on phenobarbital serum levels in children and adults.
    Fernandez de Gatta MR; Alonso Gonzalez AC; Garcia Sanchez MJ; Dominguez-Gil Hurle A; Santos Borbujo J; Monzon Corral L
    Ther Drug Monit; 1986; 8(4):416-20. PubMed ID: 3103264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Is sodium valproate bioavailability only altered by food intake?].
    Bruguerolle B; Valli M; Jadot G; Bouyard L; Bouyard P
    Nouv Presse Med; 1980 Jan; 9(1):44. PubMed ID: 6766550
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of anticonvulsants on serum protein binding of 14C-diazepam].
    Mimaki T; Suzuki Y; Tagawa T; Tanaka J; Terada H; Itoh N; Harada S; Yabuuchi H
    No To Hattatsu; 1985 Nov; 17(6):485-90. PubMed ID: 3936522
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.